FDA Approves ViiV HIV Integrase Inhibitor Dolutegravir

... that our singular focus on HIV can deliver important new medicines, maintaining our absolute commitment to the HIV/AIDS global response," said Dr Dominique Limet, Chief Executive Officer, ViiV Healthcare. The submission included data from four ...

http://www.hivandhepatitis.com/hiv-aids/hiv-aids-topics/hiv-treatment/4252-fda-approves-viiv-hiv-integrase-inhibitor-dolutegravir-tivicay